ResearcherUniversity of VeronaNo recent work listed
Claudia Fiorini
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper
Papers 7
- Loss of FGFR4 promotes the malignant phenotype of PDAC. Co-author DOI 10.1038/s41388-022-02432-5↗
- MAP Kinase inhibition reshapes tumor microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages Co-author DOI 10.1101/759779↗
- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. Co-author DOI 10.1016/j.bbamcr.2014.10.003↗
- Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. Co-author DOI 10.1016/j.bbamcr.2014.12.016↗
- Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells. Co-author DOI 10.1016/j.bbamcr.2014.01.025↗
- Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. Co-author DOI 10.1007/s10495-012-0790-6↗
- UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. First author DOI 10.1016/j.bbamcr.2012.10.028↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Massimo Donadelli · 5 shared papers, 2013–2015 · strength 0.26
- Paper Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-d… DOI 10.1016/j.bbamcr.2014.12.016↗
- Paper Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. DOI 10.1016/j.bbamcr.2014.10.003↗
- Paper Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells. DOI 10.1016/j.bbamcr.2014.01.025↗
- Francesca Lupo · 2 shared papers, 2019–2022 · strength 0.18
- Vincenzo Corbo · 2 shared papers, 2019–2022 · strength 0.18
- Pietro Delfino · 2 shared papers, 2019–2022 · strength 0.18
- Sabrina L. D’Agosto · 2 shared papers, 2019–2022 · strength 0.18
- Rita Teresa Lawlor · 2 shared papers, 2019–2022 · strength 0.18
- Elena Fiorini · 2 shared papers, 2019–2022 · strength 0.18
- Aldo Scarpa · 2 shared papers, 2019–2022 · strength 0.18
- Marco Cordani · 2 shared papers, 2015 · strength 0.12
- Antonio Pea · 1 shared paper, 2022 · strength 0.11
- Peter J. Bailey · 1 shared paper, 2022 · strength 0.11
- Antonia Malinova · 1 shared paper, 2022 · strength 0.11
- Lisa Veghini · 1 shared paper, 2022 · strength 0.11
- Claudio Luchini · 1 shared paper, 2022 · strength 0.11
- Michèle Milella · 1 shared paper, 2022 · strength 0.11
- Claudio Bassi · 1 shared paper, 2022 · strength 0.11
- Elisa Dalla Pozza · 2 shared papers, 2013 · strength 0.08
- Marta Palmieri · 2 shared papers, 2013 · strength 0.08
- Ilaria Dando · 2 shared papers, 2013 · strength 0.08
- Matteo Fassan · 1 shared paper, 2019 · strength 0.07
- Phyllis F. Cheung · 1 shared paper, 2019 · strength 0.07
- Michele Simbolo · 1 shared paper, 2019 · strength 0.07
- Vincenzo Bronte · 1 shared paper, 2019 · strength 0.07
- Francesco De Sanctis · 1 shared paper, 2019 · strength 0.07
- Jens Thomas Siveke · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.